Managing Toxicities of Ropeginterferon Alpha-2b in Patients

Joe Scandura, MD, PhD, summarizes the toxicity profile of interferon therapy in patients with polycythemia vera.

Related Keywords

Joe Scandura , Ropeginterferon Alpha , , Treatment Approach , Expert Insights Into , Polycythemia Vera , Patients With , Pv , Treatment Advanced Polycythemia Vera , Polycythemia Vera Treatments , Pv Treatments , Risk Assessment Polycythemia Vera , Patients With Polycythemia Vera , Health Insurance , Health Insurance Approvals , Nccn Guidelines , Co Pay , Community Clinics , Community Physicians , Patient Assistance Programs , Financial Toxicity , Mpns , Myeloproliferative Neoplasms , Phlebotomy , Iron Availability ,